Accordingly, a single nucleotide polymorphism (SNP) in SOCS1 rs243327 was associated with the risk of primary resistance to imatinib in CML. This evidence concerns the gene SOCS1 and chronic myelogenous leukemia, BCR-ABL1 positive.